Clustering of metabolic and cardiovascular risk factors in the Polycystic ovary syndrome: A principal component analysis

Bronwyn Stuckey, N. Opie, A.J. Cussons, Gerald Watts, Valerie Burke

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Context Polycystic ovary syndrome (PCOS) is a prevalent condition with heterogeneity of clinical features and cardiovascular risk factors that implies multiple aetiological factors and possible outcomes. Objective To reduce a set of correlated variables to a smaller number of uncorrelated and interpretable factors that may delineate subgroups within PCOS or suggest pathogenetic mechanisms. Materials and methods We used principal component analysis (PCA) to examine the endocrine and cardiometabolic variables associated with PCOS defined by the National Institutes of Health (NIH) criteria. Data were retrieved from the database of a single clinical endocrinologist. We included women with PCOS (N = 378) who were not taking the oral contraceptive pill or other sex hormones, lipid lowering medication, metformin or other medication that could influence the variables of interest. PCA was performed retaining those factors with eigenvalues of at least 1.0. Varimax rotation was used to produce interpretable factors. Results We identified three principal components. In component 1, the dominant variables were homeostatic model assessment (HOMA) index, body mass index (BMI), high density lipoprotein (HDL) cholesterol and sex hormone binding globulin (SHBG); in component 2, systolic blood pressure, low density lipoprotein (LDL) cholesterol and triglycerides; in component 3, total testosterone and LH/FSH ratio. These components explained 37%, 13% and 11% of the variance in the PCOS cohort respectively. Conclusions Multiple correlated variables from patients with PCOS can be reduced to three uncorrelated components characterised by insulin resistance, dyslipidaemia/hypertension or hyperandrogenaemia. Clustering of risk factors is consistent with different pathogenetic pathways within PCOS and/or differing cardiometabolic outcomes. © 2014 Elsevier Inc.
Original languageEnglish
Pages (from-to)1071-1077
JournalMetabolism: clinical and experimental
Volume63
Issue number8
DOIs
Publication statusPublished - 2014

Fingerprint Dive into the research topics of 'Clustering of metabolic and cardiovascular risk factors in the Polycystic ovary syndrome: A principal component analysis'. Together they form a unique fingerprint.

Cite this